Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Pharmaceutical industry news

Show

From To
A powerful push for Gilead's patent in India

The US commerce secretary lobbying his counterpart in another country on behalf of a company is rare, but not unknown, and in early November, just days ahead of US President Barack Obama’s visit to India, Gary Locke did just that, writing to India’s Anand Sharma seeking “fair consideration” of Gilead Sciences Inc.’s patent appeal in India.

Published
17 December 2010
From
LiveMint.com
SECTION27 and TAC applaud successful ARV medicine tender – but call for continued actions to drive prices of essential medicines down further

SECTION27 and TAC applaud the Minister of Health and his team at the Department of Health (DoH) for their part in conceptualising, implementing and concluding a successful antiretroviral (ARV) medicine tender.

Published
16 December 2010
From
Treatment Action Campaign
South Africa to double HIV patient treatment

South Africa's health minister says he has brought down the cost of HIV drugs by 53 percent, enabling the government to treat twice as many patients in the next two years.

Published
14 December 2010
From
Washington Post
S. African pharma Adcock's portion of ARV tender falls, shares drop

South African drug maker Adcock Ingram suffered a sharp drop in its share of a lucrative government HIV/AIDS drug supply contract, company figures showed on Tuesday, sending its share price down more than 5 percent.

Published
14 December 2010
From
Reuters
Deal spells doom for our chronically sick

"By sacrificing Africa, India could gain a bigger market in Europe for lifestyle diseases, while at the same time protecting its own products. This move confirms the truth in the adage — while India and the likes of Brazil chose to learn how to fish, we opted for handouts."

Published
13 December 2010
From
Daily Nation (Nairobi)
Trade agreements should not hinder efforts towards universal access to HIV prevention, treatment, care and support

The Joint United Nations Programme on HIV/AIDS (UNAIDS) calls on all countries to ensure efforts towards universal access to HIV prevention, treatment, care and support are not impeded by bilateral and multilateral trade agreements.

Published
09 December 2010
From
UNAIDS
Abbott receives FDA approval for first automated molecular test for assessing hepatitis B treatment

Abbott announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood.

Published
01 September 2010
From
Abbott
GSK and Pfizer HIV divisions to form new company

GlaxoSmithKline (GSK) and Pfizer have merged the HIV sections of their business to form a new company. In a statement issued on April 16th, they

Published
17 April 2009
By
Michael Carter
WHO issues guidance for doctors, governments, patients on what to do about delisted ARVs

WHO advice after delisting of a number of generic antiretroviral products.

Published
03 September 2004
From
HIV & AIDS treatment in practice
GSK cuts price of HIV drugs to poorest countries

Pharmaceutical giant, GlaxoSmithKline (GSK), has announced that it is halving the price of some of the drugs in its anti-HIV portfolio for 63 nations, including

Published
28 April 2003
By
Michael Carter

Filter by country